

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.76956557 |
| 2 | negative T cell selection (GO:0043383) | 6.27251768 |
| 3 | interferon-gamma production (GO:0032609) | 5.97778132 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.91653119 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.66834038 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.66834038 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.48689461 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.48689461 |
| 9 | positive T cell selection (GO:0043368) | 5.44098987 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.33337099 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.26987747 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.17783234 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.16005816 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 5.11937586 |
| 15 | T cell selection (GO:0045058) | 5.11790423 |
| 16 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.08826587 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07105968 |
| 18 | regulation of T cell tolerance induction (GO:0002664) | 5.03469075 |
| 19 | thymic T cell selection (GO:0045061) | 4.96976232 |
| 20 | cellular response to interleukin-15 (GO:0071350) | 4.95545273 |
| 21 | tolerance induction (GO:0002507) | 4.89699919 |
| 22 | T cell migration (GO:0072678) | 4.88818928 |
| 23 | response to interleukin-15 (GO:0070672) | 4.84040696 |
| 24 | T cell receptor signaling pathway (GO:0050852) | 4.60332459 |
| 25 | regulation of regulatory T cell differentiation (GO:0045589) | 4.51162511 |
| 26 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.42903446 |
| 27 | positive regulation of interleukin-2 production (GO:0032743) | 4.24563345 |
| 28 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.23949004 |
| 29 | leukocyte aggregation (GO:0070486) | 4.19400550 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17812765 |
| 31 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.10620616 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.10507571 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09215230 |
| 34 | positive regulation of tolerance induction (GO:0002645) | 4.03751188 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.96775524 |
| 36 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.95606715 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.94587375 |
| 38 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.92682264 |
| 39 | regulation of tolerance induction (GO:0002643) | 3.88833064 |
| 40 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.87127640 |
| 41 | mast cell activation (GO:0045576) | 3.85734063 |
| 42 | alpha-beta T cell differentiation (GO:0046632) | 3.78171969 |
| 43 | alpha-beta T cell activation (GO:0046631) | 3.78131229 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.77559452 |
| 45 | T cell costimulation (GO:0031295) | 3.77110021 |
| 46 | lymphocyte costimulation (GO:0031294) | 3.74025146 |
| 47 | activated T cell proliferation (GO:0050798) | 3.72842927 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.72052572 |
| 49 | regulation of cell killing (GO:0031341) | 3.68316989 |
| 50 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.68068207 |
| 51 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.63912443 |
| 52 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.60696471 |
| 53 | positive regulation of isotype switching (GO:0045830) | 3.52593710 |
| 54 | positive regulation of DNA recombination (GO:0045911) | 3.52132150 |
| 55 | T cell differentiation (GO:0030217) | 3.51755454 |
| 56 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.48747093 |
| 57 | T-helper cell differentiation (GO:0042093) | 3.48747093 |
| 58 | mast cell degranulation (GO:0043303) | 3.48627593 |
| 59 | mast cell activation involved in immune response (GO:0002279) | 3.48627593 |
| 60 | positive regulation of defense response to virus by host (GO:0002230) | 3.44693473 |
| 61 | regulation of isotype switching (GO:0045191) | 3.38017074 |
| 62 | regulation of memory T cell differentiation (GO:0043380) | 3.32788422 |
| 63 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.32734045 |
| 64 | regulation of T cell mediated immunity (GO:0002709) | 3.32349952 |
| 65 | leukocyte degranulation (GO:0043299) | 3.31760008 |
| 66 | positive regulation of cell killing (GO:0031343) | 3.30783561 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30476364 |
| 68 | positive regulation of T cell mediated immunity (GO:0002711) | 3.28019933 |
| 69 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.27447479 |
| 70 | dendritic cell migration (GO:0036336) | 3.24048470 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.22747225 |
| 72 | response to type I interferon (GO:0034340) | 3.21522208 |
| 73 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21345584 |
| 74 | neutrophil activation (GO:0042119) | 3.20952545 |
| 75 | T cell homeostasis (GO:0043029) | 3.19073704 |
| 76 | regulation of germinal center formation (GO:0002634) | 3.18680214 |
| 77 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.17082280 |
| 78 | lymph node development (GO:0048535) | 3.16265075 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 3.14555061 |
| 80 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.14537557 |
| 81 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.14519467 |
| 82 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.14519467 |
| 83 | T cell differentiation involved in immune response (GO:0002292) | 3.14519467 |
| 84 | regulation of interleukin-2 production (GO:0032663) | 3.14426830 |
| 85 | type I interferon signaling pathway (GO:0060337) | 3.13967033 |
| 86 | cellular response to type I interferon (GO:0071357) | 3.13967033 |
| 87 | positive regulation of humoral immune response (GO:0002922) | 3.13406537 |
| 88 | regulation of B cell differentiation (GO:0045577) | 3.12286138 |
| 89 | negative regulation of innate immune response (GO:0045824) | 3.11688992 |
| 90 | T cell activation (GO:0042110) | 3.10993029 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.08885900 |
| 92 | natural killer cell activation (GO:0030101) | 3.08078415 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 3.07685159 |
| 94 | negative regulation of adaptive immune response (GO:0002820) | 3.07027608 |
| 95 | mature B cell differentiation (GO:0002335) | 3.06402651 |
| 96 | cellular response to interferon-beta (GO:0035458) | 3.06341352 |
| 97 | V(D)J recombination (GO:0033151) | 3.03190222 |
| 98 | protein K11-linked deubiquitination (GO:0035871) | 3.02766962 |
| 99 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.02471079 |
| 100 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.01455927 |
| 101 | T cell lineage commitment (GO:0002360) | 3.01107553 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00497751 |
| 103 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97993567 |
| 104 | B cell proliferation (GO:0042100) | 2.94466717 |
| 105 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.94418416 |
| 106 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.94418416 |
| 107 | DNA deamination (GO:0045006) | 2.93981245 |
| 108 | regulation of immunoglobulin production (GO:0002637) | 2.93866053 |
| 109 | leukocyte cell-cell adhesion (GO:0007159) | 2.93376425 |
| 110 | positive regulation of interferon-gamma production (GO:0032729) | 2.92979787 |
| 111 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.92631191 |
| 112 | positive regulation of B cell mediated immunity (GO:0002714) | 2.92631191 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.90740240 |
| 114 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89567676 |
| 115 | regulation of defense response to virus by host (GO:0050691) | 2.88658978 |
| 116 | regulation of alpha-beta T cell activation (GO:0046634) | 2.88318061 |
| 117 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.88154310 |
| 118 | T cell activation involved in immune response (GO:0002286) | 2.87815988 |
| 119 | lymphocyte homeostasis (GO:0002260) | 2.87690405 |
| 120 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86713272 |
| 121 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86713272 |
| 122 | cellular extravasation (GO:0045123) | 2.85664170 |
| 123 | positive regulation of immunoglobulin production (GO:0002639) | 2.84642862 |
| 124 | cellular defense response (GO:0006968) | 2.84173904 |
| 125 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84020588 |
| 126 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.83738465 |
| 127 | regulation of B cell mediated immunity (GO:0002712) | 2.83622764 |
| 128 | ribosomal small subunit assembly (GO:0000028) | 2.82979108 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.82746571 |
| 130 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.81978016 |
| 131 | T cell proliferation (GO:0042098) | 2.81786234 |
| 132 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.81348153 |
| 133 | positive regulation of B cell differentiation (GO:0045579) | 2.80805110 |
| 134 | natural killer cell differentiation (GO:0001779) | 2.76989803 |
| 135 | Peyers patch development (GO:0048541) | 2.76469325 |
| 136 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.76469325 |
| 137 | granulocyte activation (GO:0036230) | 2.76442603 |
| 138 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.74933084 |
| 139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.73646399 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.73646399 |
| 141 | myeloid cell activation involved in immune response (GO:0002275) | 2.73564184 |
| 142 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.70925385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.96056632 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.00221847 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.30609763 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65153273 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.82173950 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.77904825 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.71469827 |
| 8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.64975911 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.11127991 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.93710434 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.93532735 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.85932472 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.84443821 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75045359 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50046059 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41133957 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40018175 |
| 18 | * MYB_26560356_Chip-Seq_TH1_Human | 2.32516811 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09232227 |
| 20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05345684 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01163859 |
| 22 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97289725 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.93886148 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.91621626 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89404688 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85640169 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85585086 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.82232181 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79257152 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77258085 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76879794 |
| 32 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.75231448 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63475855 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58764593 |
| 35 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52927948 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50681578 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49913386 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45848299 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37693487 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36957343 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.36217369 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32472582 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22921176 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20696060 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18629430 |
| 46 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17488796 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14896980 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13444169 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12621679 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12583274 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12032183 |
| 52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11815110 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10570542 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07821753 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07472964 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07129287 |
| 57 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06742307 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06488570 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06452843 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05406871 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05310846 |
| 62 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05246634 |
| 63 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03913873 |
| 64 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03624923 |
| 65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02838981 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02619935 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01999847 |
| 68 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.01826280 |
| 69 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.01487961 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99773118 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98862053 |
| 72 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98416149 |
| 73 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98282470 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97873496 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97835318 |
| 76 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97793110 |
| 77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97493994 |
| 78 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95217914 |
| 79 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95179751 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94696476 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94064800 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93056923 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89631112 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88529014 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87578645 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87366240 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87330991 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86925531 |
| 89 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86769107 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86763149 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.86396206 |
| 92 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85289066 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84574857 |
| 94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.84168431 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 0.84035378 |
| 96 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.83818731 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.83631457 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83153497 |
| 99 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82845167 |
| 100 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.82756511 |
| 101 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82680726 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.81478953 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81233152 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81021496 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.80130690 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79795334 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79740498 |
| 108 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79699639 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79280340 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.78924692 |
| 111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78349783 |
| 112 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.78341817 |
| 113 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.77551866 |
| 114 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77417656 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.77178016 |
| 116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77148841 |
| 117 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76939985 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76587846 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76210146 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75664879 |
| 121 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75621674 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75594777 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75385777 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75355154 |
| 125 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75342780 |
| 126 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.75260437 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75119750 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.74466526 |
| 129 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.74206781 |
| 130 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.72864337 |
| 131 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.72443450 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72395589 |
| 133 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.72046614 |
| 134 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.71473050 |
| 135 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.71473050 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71411458 |
| 137 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71384395 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.70941588 |
| 139 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.70764204 |
| 140 | P300_19829295_ChIP-Seq_ESCs_Human | 0.70209980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.20357263 |
| 2 | MP0005671_abnormal_response_to | 4.09482318 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.80492434 |
| 4 | MP0000685_abnormal_immune_system | 3.24136880 |
| 5 | MP0005387_immune_system_phenotype | 3.21936366 |
| 6 | MP0001790_abnormal_immune_system | 3.21936366 |
| 7 | MP0001800_abnormal_humoral_immune | 3.18354826 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.88050617 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.74812635 |
| 10 | MP0002723_abnormal_immune_serum | 2.74312089 |
| 11 | MP0001819_abnormal_immune_cell | 2.70932781 |
| 12 | MP0001873_stomach_inflammation | 2.64352322 |
| 13 | MP0009785_altered_susceptibility_to | 2.61977833 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.60341837 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.57137567 |
| 16 | MP0003866_abnormal_defecation | 2.47691082 |
| 17 | MP0002398_abnormal_bone_marrow | 2.47683519 |
| 18 | MP0005025_abnormal_response_to | 2.30446328 |
| 19 | MP0010155_abnormal_intestine_physiology | 2.29601979 |
| 20 | MP0000716_abnormal_immune_system | 2.24527300 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.22329641 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.18379424 |
| 23 | MP0002163_abnormal_gland_morphology | 2.15057533 |
| 24 | MP0003724_increased_susceptibility_to | 2.11813809 |
| 25 | MP0002405_respiratory_system_inflammati | 2.05743869 |
| 26 | MP0002006_tumorigenesis | 2.05605427 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.05210562 |
| 28 | MP0004381_abnormal_hair_follicle | 1.94958663 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.92202974 |
| 30 | MP0002722_abnormal_immune_system | 1.90953706 |
| 31 | MP0002009_preneoplasia | 1.89385055 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.87085382 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.86476504 |
| 34 | MP0003787_abnormal_imprinting | 1.81281837 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.80091431 |
| 36 | MP0002419_abnormal_innate_immunity | 1.79802807 |
| 37 | MP0003436_decreased_susceptibility_to | 1.77147151 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.76957175 |
| 39 | MP0002429_abnormal_blood_cell | 1.71636121 |
| 40 | MP0005310_abnormal_salivary_gland | 1.70399636 |
| 41 | MP0002822_catalepsy | 1.66561691 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.64497438 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.61798998 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.61472298 |
| 45 | MP0006082_CNS_inflammation | 1.58405314 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.54488036 |
| 47 | MP0003878_abnormal_ear_physiology | 1.54187199 |
| 48 | MP0005377_hearing/vestibular/ear_phenot | 1.54187199 |
| 49 | MP0004947_skin_inflammation | 1.52534713 |
| 50 | MP0000490_abnormal_crypts_of | 1.49695870 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.44285086 |
| 52 | MP0002132_abnormal_respiratory_system | 1.40886899 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.39709403 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.30577665 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.29301595 |
| 56 | MP0004130_abnormal_muscle_cell | 1.25023591 |
| 57 | MP0009379_abnormal_foot_pigmentation | 1.23906263 |
| 58 | MP0002933_joint_inflammation | 1.22353344 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.20944506 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.19500561 |
| 61 | MP0004510_myositis | 1.19201638 |
| 62 | MP0002638_abnormal_pupillary_reflex | 1.17598960 |
| 63 | MP0001853_heart_inflammation | 1.16819912 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.14055041 |
| 65 | MP0001188_hyperpigmentation | 1.11971468 |
| 66 | MP0000858_altered_metastatic_potential | 1.10066964 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.08324023 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.07007164 |
| 69 | MP0002095_abnormal_skin_pigmentation | 1.05079928 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.02247418 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.01400143 |
| 72 | MP0001919_abnormal_reproductive_system | 0.98516810 |
| 73 | MP0001663_abnormal_digestive_system | 0.97742868 |
| 74 | MP0003252_abnormal_bile_duct | 0.97206997 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.94364076 |
| 76 | MP0008057_abnormal_DNA_replication | 0.92763891 |
| 77 | MP0002102_abnormal_ear_morphology | 0.92100041 |
| 78 | MP0004142_abnormal_muscle_tone | 0.85054920 |
| 79 | MP0003646_muscle_fatigue | 0.83087615 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.82876263 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.82401897 |
| 82 | MP0008469_abnormal_protein_level | 0.81807665 |
| 83 | MP0003195_calcinosis | 0.77838639 |
| 84 | MP0002735_abnormal_chemical_nociception | 0.75079516 |
| 85 | MP0004043_abnormal_pH_regulation | 0.74862375 |
| 86 | MP0003828_pulmonary_edema | 0.74377740 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.73148568 |
| 88 | MP0003045_fibrosis | 0.71320937 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.70380772 |
| 90 | MP0008872_abnormal_physiological_respon | 0.70373131 |
| 91 | MP0003448_altered_tumor_morphology | 0.69921403 |
| 92 | MP0009278_abnormal_bone_marrow | 0.69536467 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68312309 |
| 94 | MP0005409_darkened_coat_color | 0.67966892 |
| 95 | MP0003011_delayed_dark_adaptation | 0.67630356 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.67556245 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.66587484 |
| 98 | MP0004883_abnormal_blood_vessel | 0.66315343 |
| 99 | MP0009764_decreased_sensitivity_to | 0.65668718 |
| 100 | MP0000613_abnormal_salivary_gland | 0.65545542 |
| 101 | MP0008995_early_reproductive_senescence | 0.63989128 |
| 102 | MP0009763_increased_sensitivity_to | 0.63479953 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.61548992 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.59797093 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.57687008 |
| 106 | MP0001905_abnormal_dopamine_level | 0.57621913 |
| 107 | MP0005390_skeleton_phenotype | 0.56961465 |
| 108 | MP0001664_abnormal_digestion | 0.56850005 |
| 109 | MP0008058_abnormal_DNA_repair | 0.56780715 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.56422921 |
| 111 | MP0005389_reproductive_system_phenotype | 0.53214858 |
| 112 | MP0000604_amyloidosis | 0.53008176 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.52253911 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.52226101 |
| 115 | MP0003786_premature_aging | 0.51206305 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.51070520 |
| 117 | MP0004742_abnormal_vestibular_system | 0.50129197 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.48461679 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.48003424 |
| 120 | MP0002928_abnormal_bile_duct | 0.47733416 |
| 121 | MP0003303_peritoneal_inflammation | 0.47494965 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.47214603 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.46856170 |
| 124 | MP0001545_abnormal_hematopoietic_system | 0.46856170 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.45882760 |
| 126 | MP0001851_eye_inflammation | 0.44873571 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.44453480 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.44390576 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.42223777 |
| 130 | MP0006054_spinal_hemorrhage | 0.41849303 |
| 131 | MP0008569_lethality_at_weaning | 0.40677780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.91800818 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.74250179 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.70142940 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 4.34258828 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 4.31400230 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.29254425 |
| 7 | Abnormality of T cells (HP:0002843) | 4.29066493 |
| 8 | IgM deficiency (HP:0002850) | 4.24252236 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.07620452 |
| 10 | Agammaglobulinemia (HP:0004432) | 3.97548266 |
| 11 | Recurrent viral infections (HP:0004429) | 3.93106478 |
| 12 | Combined immunodeficiency (HP:0005387) | 3.92702631 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.92578611 |
| 14 | Stomatitis (HP:0010280) | 3.91931456 |
| 15 | Thyroiditis (HP:0100646) | 3.86701717 |
| 16 | Increased IgM level (HP:0003496) | 3.77971753 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77781798 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77781798 |
| 19 | IgG deficiency (HP:0004315) | 3.73777998 |
| 20 | Chronic otitis media (HP:0000389) | 3.66517957 |
| 21 | Abnormality of the fingertips (HP:0001211) | 3.58781112 |
| 22 | Abnormality of eosinophils (HP:0001879) | 3.48287413 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.41802096 |
| 24 | Pustule (HP:0200039) | 3.38963423 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.35729718 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.34772934 |
| 27 | Eosinophilia (HP:0001880) | 3.33399135 |
| 28 | Cheilitis (HP:0100825) | 3.33020449 |
| 29 | Chronic diarrhea (HP:0002028) | 3.29721029 |
| 30 | Meningitis (HP:0001287) | 3.29655535 |
| 31 | Abnormality of B cell number (HP:0010975) | 3.21709735 |
| 32 | B lymphocytopenia (HP:0010976) | 3.21709735 |
| 33 | Myositis (HP:0100614) | 3.20301993 |
| 34 | Lymphopenia (HP:0001888) | 3.16874505 |
| 35 | Chronic sinusitis (HP:0011109) | 3.08898380 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 3.06208443 |
| 37 | Hypothermia (HP:0002045) | 3.04840701 |
| 38 | Vasculitis (HP:0002633) | 3.02833319 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.99456447 |
| 40 | Granulocytopenia (HP:0001913) | 2.97251206 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.96925045 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.92983110 |
| 43 | Optic neuritis (HP:0100653) | 2.90004120 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.90004120 |
| 45 | Recurrent sinusitis (HP:0011108) | 2.87480498 |
| 46 | Abnormal hair whorl (HP:0010721) | 2.87235397 |
| 47 | Nasal polyposis (HP:0100582) | 2.86992861 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.85756151 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.85686524 |
| 50 | Encephalitis (HP:0002383) | 2.69027393 |
| 51 | Obstructive lung disease (HP:0006536) | 2.67265323 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67265323 |
| 53 | Leukocytosis (HP:0001974) | 2.66529050 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.65999773 |
| 55 | Joint swelling (HP:0001386) | 2.62688895 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.62302186 |
| 57 | Anorexia (HP:0002039) | 2.59886882 |
| 58 | Hemoptysis (HP:0002105) | 2.52864854 |
| 59 | Lymphoma (HP:0002665) | 2.47653586 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.46588777 |
| 61 | Pulmonary embolism (HP:0002204) | 2.45854345 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.45370681 |
| 63 | Prolonged bleeding time (HP:0003010) | 2.44003396 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.38430630 |
| 65 | Recurrent skin infections (HP:0001581) | 2.33008424 |
| 66 | Bronchiectasis (HP:0002110) | 2.32736333 |
| 67 | Hypoplasia of the thymus (HP:0000778) | 2.32279690 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.31909418 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.29006099 |
| 70 | Orchitis (HP:0100796) | 2.28630417 |
| 71 | Bronchitis (HP:0012387) | 2.27846429 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27185010 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 2.25678594 |
| 74 | IgA deficiency (HP:0002720) | 2.25109993 |
| 75 | Chest pain (HP:0100749) | 2.23248353 |
| 76 | Gangrene (HP:0100758) | 2.23133093 |
| 77 | Verrucae (HP:0200043) | 2.20590022 |
| 78 | Papilloma (HP:0012740) | 2.20590022 |
| 79 | Hypochromic anemia (HP:0001931) | 2.16563940 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.16480060 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.14341048 |
| 82 | Colitis (HP:0002583) | 2.12893647 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.12577249 |
| 84 | Attenuation of retinal blood vessels (HP:0007843) | 2.12448507 |
| 85 | Renal cortical cysts (HP:0000803) | 2.09156307 |
| 86 | Alveolar cell carcinoma (HP:0006519) | 2.08712286 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.05441389 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04754492 |
| 89 | Periodontitis (HP:0000704) | 2.04307295 |
| 90 | Gingivitis (HP:0000230) | 2.00915986 |
| 91 | Episodic fever (HP:0001954) | 1.98794839 |
| 92 | Ureteral stenosis (HP:0000071) | 1.97922989 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97901282 |
| 94 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.97276218 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 1.97014598 |
| 96 | Petechiae (HP:0000967) | 1.95545974 |
| 97 | Pulmonary fibrosis (HP:0002206) | 1.95517924 |
| 98 | Prostate neoplasm (HP:0100787) | 1.94421645 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 1.94177539 |
| 100 | Vertigo (HP:0002321) | 1.92445419 |
| 101 | Hypoproteinemia (HP:0003075) | 1.91538143 |
| 102 | Ureteral obstruction (HP:0006000) | 1.91350153 |
| 103 | Increased IgE level (HP:0003212) | 1.90646209 |
| 104 | Hematochezia (HP:0002573) | 1.90416837 |
| 105 | Stomach cancer (HP:0012126) | 1.89975180 |
| 106 | Abnormality of the renal cortex (HP:0011035) | 1.89554641 |
| 107 | Thrombocytosis (HP:0001894) | 1.88528166 |
| 108 | Recurrent otitis media (HP:0000403) | 1.88244216 |
| 109 | Lip pit (HP:0100267) | 1.87949775 |
| 110 | Urticaria (HP:0001025) | 1.87333323 |
| 111 | Optic nerve coloboma (HP:0000588) | 1.85334437 |
| 112 | Dry hair (HP:0011359) | 1.84342622 |
| 113 | Sepsis (HP:0100806) | 1.83395440 |
| 114 | Glomerulopathy (HP:0100820) | 1.82305255 |
| 115 | Neutropenia (HP:0001875) | 1.80689156 |
| 116 | Clumsiness (HP:0002312) | 1.80019838 |
| 117 | Hemiplegia (HP:0002301) | 1.78490457 |
| 118 | Gingival bleeding (HP:0000225) | 1.76284595 |
| 119 | Epistaxis (HP:0000421) | 1.75353842 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74202809 |
| 121 | Microcytic anemia (HP:0001935) | 1.71694447 |
| 122 | Abnormality of DNA repair (HP:0003254) | 1.71692443 |
| 123 | Keratitis (HP:0000491) | 1.70371313 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69804463 |
| 125 | Keratoconjunctivitis sicca (HP:0001097) | 1.69463852 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69070502 |
| 127 | Arterial thrombosis (HP:0004420) | 1.68059936 |
| 128 | Cellulitis (HP:0100658) | 1.65850984 |
| 129 | Type I transferrin isoform profile (HP:0003642) | 1.65698626 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.63853201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.72306785 |
| 2 | MAP4K1 | 5.32711284 |
| 3 | JAK3 | 2.96172687 |
| 4 | NLK | 2.91282072 |
| 5 | MAP3K14 | 2.80035508 |
| 6 | ITK | 2.66596429 |
| 7 | IKBKE | 2.49682839 |
| 8 | ZAP70 | 2.43974446 |
| 9 | MST4 | 2.41294689 |
| 10 | GRK6 | 2.34661642 |
| 11 | TEC | 2.28217919 |
| 12 | IRAK4 | 2.03540253 |
| 13 | TYK2 | 1.88648779 |
| 14 | IRAK3 | 1.86376380 |
| 15 | STK10 | 1.83655198 |
| 16 | FGFR4 | 1.81834564 |
| 17 | TESK2 | 1.77478031 |
| 18 | BTK | 1.61472375 |
| 19 | JAK1 | 1.60765518 |
| 20 | LCK | 1.60174807 |
| 21 | MAP3K13 | 1.59247403 |
| 22 | SYK | 1.59049336 |
| 23 | FGFR3 | 1.52822936 |
| 24 | MAP2K2 | 1.48453214 |
| 25 | IKBKB | 1.44649799 |
| 26 | SIK3 | 1.41700930 |
| 27 | MAP3K12 | 1.39118051 |
| 28 | TLK1 | 1.36459015 |
| 29 | TNIK | 1.24275622 |
| 30 | CAMKK2 | 1.22814063 |
| 31 | KDR | 1.19288543 |
| 32 | PRKCQ | 1.19248189 |
| 33 | TBK1 | 1.16292221 |
| 34 | MARK3 | 1.16056771 |
| 35 | BLK | 1.14844744 |
| 36 | TGFBR2 | 1.09102767 |
| 37 | HCK | 1.08333914 |
| 38 | YES1 | 1.07376923 |
| 39 | FRK | 1.07051104 |
| 40 | ADRBK2 | 1.06925690 |
| 41 | TNK2 | 1.05020309 |
| 42 | CHUK | 1.04098951 |
| 43 | MAP3K10 | 1.01972726 |
| 44 | CSK | 1.01038293 |
| 45 | NUAK1 | 1.00482179 |
| 46 | BCKDK | 0.99304397 |
| 47 | IRAK1 | 0.96723015 |
| 48 | STK24 | 0.95413991 |
| 49 | PRKCH | 0.89134588 |
| 50 | PRKD2 | 0.88635165 |
| 51 | FLT3 | 0.88348019 |
| 52 | KIT | 0.87716538 |
| 53 | HIPK2 | 0.85696290 |
| 54 | NME2 | 0.85488336 |
| 55 | SIK2 | 0.85313358 |
| 56 | PIM1 | 0.84709544 |
| 57 | LYN | 0.84676672 |
| 58 | PINK1 | 0.84559165 |
| 59 | BMPR2 | 0.83022028 |
| 60 | EPHA3 | 0.82055897 |
| 61 | CLK1 | 0.79883895 |
| 62 | GRK7 | 0.79683477 |
| 63 | CASK | 0.79403394 |
| 64 | MAP4K2 | 0.75992367 |
| 65 | CAMKK1 | 0.70767127 |
| 66 | EIF2AK2 | 0.67056622 |
| 67 | FYN | 0.65177164 |
| 68 | MAPK7 | 0.64675422 |
| 69 | MAPK11 | 0.64486601 |
| 70 | ERN1 | 0.64116627 |
| 71 | MAP3K11 | 0.63504053 |
| 72 | EIF2AK3 | 0.63031703 |
| 73 | PDK1 | 0.62696224 |
| 74 | MAPK13 | 0.62616783 |
| 75 | INSRR | 0.62517226 |
| 76 | MAP3K7 | 0.62254153 |
| 77 | MAP2K7 | 0.61598873 |
| 78 | LMTK2 | 0.61058428 |
| 79 | MAP2K6 | 0.60956995 |
| 80 | RIPK4 | 0.60834125 |
| 81 | FGR | 0.60271637 |
| 82 | TRPM7 | 0.60112865 |
| 83 | TAOK3 | 0.59815237 |
| 84 | BMPR1B | 0.56980614 |
| 85 | EPHB1 | 0.55755609 |
| 86 | BRD4 | 0.55450166 |
| 87 | PASK | 0.54875924 |
| 88 | IRAK2 | 0.53550533 |
| 89 | PIK3CA | 0.53547510 |
| 90 | PRKG2 | 0.53477086 |
| 91 | JAK2 | 0.51832071 |
| 92 | ADRBK1 | 0.51751532 |
| 93 | MATK | 0.51392317 |
| 94 | SGK2 | 0.51064678 |
| 95 | GRK1 | 0.46990431 |
| 96 | FES | 0.45495953 |
| 97 | STK4 | 0.45474488 |
| 98 | MUSK | 0.44974570 |
| 99 | ACVR1B | 0.44557852 |
| 100 | TAOK1 | 0.43863193 |
| 101 | ZAK | 0.43281541 |
| 102 | MARK2 | 0.39839675 |
| 103 | ERBB3 | 0.39775068 |
| 104 | CSF1R | 0.39574499 |
| 105 | NTRK2 | 0.39123693 |
| 106 | PTK2B | 0.39066126 |
| 107 | NEK6 | 0.37985942 |
| 108 | PIK3CG | 0.35788098 |
| 109 | MAP3K3 | 0.35091892 |
| 110 | MAPK3 | 0.34602942 |
| 111 | STK38 | 0.34376265 |
| 112 | RPS6KA5 | 0.33664603 |
| 113 | CDK4 | 0.33344357 |
| 114 | IGF1R | 0.32326121 |
| 115 | RPS6KA6 | 0.31865999 |
| 116 | ABL1 | 0.31315850 |
| 117 | CAMK1 | 0.31014677 |
| 118 | STK11 | 0.30745527 |
| 119 | LRRK2 | 0.30609543 |
| 120 | EEF2K | 0.30112707 |
| 121 | MAPK12 | 0.29999859 |
| 122 | MAP2K3 | 0.29226210 |
| 123 | CAMK4 | 0.28600702 |
| 124 | MAPKAPK2 | 0.28399232 |
| 125 | MAP3K1 | 0.28277655 |
| 126 | INSR | 0.27826408 |
| 127 | TGFBR1 | 0.27634318 |
| 128 | MAPK4 | 0.27101091 |
| 129 | PKN1 | 0.26543253 |
| 130 | SRPK1 | 0.26142136 |
| 131 | PRKCD | 0.25953785 |
| 132 | DYRK1A | 0.25330765 |
| 133 | VRK1 | 0.24861932 |
| 134 | PDGFRB | 0.23834417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.72536250 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.86409794 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.86036816 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46905304 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.42486169 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.37330483 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.35659376 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.24930094 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.22630588 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.20403640 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09461757 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88271043 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85281495 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68143382 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66557013 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62704267 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61209949 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56699325 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55937845 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47981623 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46326868 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45794185 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.45372497 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42204049 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.36831187 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33055303 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.28249924 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27417236 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26433966 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25379135 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20699451 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14158746 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13706683 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11729161 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11315016 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.09656713 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09421676 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.07173690 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.02864084 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99714321 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.96420504 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95858025 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93805151 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93665335 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93477586 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90965284 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90145141 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89625215 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.87459020 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85458912 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.84337607 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.84151907 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.81619137 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77272361 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76590387 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75495937 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.75434313 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74265466 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73493219 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.73162467 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70490424 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70132836 |
| 63 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69009475 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68666215 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68338706 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.67543244 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65514620 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.64497646 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.63938810 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63270940 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63158818 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61364754 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.61015606 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60382130 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58083037 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57608576 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57562436 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54223656 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52185153 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52063096 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51612414 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50201917 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49935868 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49881719 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49469415 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.48752255 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48346537 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.47819313 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47647339 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46144943 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45634336 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44720209 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.44408284 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42816236 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42665240 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.41611887 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40636162 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40232095 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38534711 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38212542 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37746664 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37277129 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37095658 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.35851139 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35538730 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33875108 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32787562 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31427713 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.30681832 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30282435 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30125357 |
| 112 | Base excision repair_Homo sapiens_hsa03410 | 0.29880883 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27613961 |
| 114 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27353840 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.26264648 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.26074515 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.25846552 |
| 118 | Spliceosome_Homo sapiens_hsa03040 | 0.25620728 |
| 119 | Morphine addiction_Homo sapiens_hsa05032 | 0.25588354 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24961288 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24835158 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24790361 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23566349 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.23215751 |
| 125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23156934 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22984613 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22777249 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.22601847 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22212137 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.21896219 |

